期刊文献+

正电子放射性药物的点击合成 被引量:3

Click synthesis of PET radiopharmaceuticals
下载PDF
导出
摘要 正电子放射性药物的合成是核技术应用领域的焦点之一。近年来点击化学因其高速、高收率、高选择性和条件温和等优点而应用于正电子放射性药物的合成。本文综述了近年来点击化学在PET药物合成中的研究进展(包括将18F和11C导入药物分子),并展望其发展前景。 Increasing attention has been focused on synthesis radiopharmaceuticals for positron emission tomography (PET). The recent years witnessed applications of click chemistry to PET radiopharmaceutical synthesis, because of its distinctive advantages including high speed, yield and stereospecificity under mild conditions. Synthesis of ^18F-labeled and ^11C-labeled radiopharmaceuticals and intermediates via click chemistry are reviewed. The future trend of click chemistry for the synthesis of PET radiopharmaceutical is prospected.
作者 许梅 匡春香
机构地区 同济大学化学系
出处 《核技术》 CAS CSCD 北大核心 2009年第8期626-631,共6页 Nuclear Techniques
基金 上海市"科技创新行动"2008年生物医药重点项目(08431902700)
关键词 PET药物 点击化学 放射性标记 铜催化 PET radiopharmaceutical, Click chemistry, Radiosynthesis, Copper-catalyzed
  • 相关文献

参考文献36

  • 1Langstrom B,Kihlberg T,Bergstom M,et al.Acta Chem Scand,1999,53(9):651-669.
  • 2Schirrmacher R,Wangler C,Schirrmacher E.Mini-Rev Org Chem,2007,4(4):317-329.
  • 3Miller P W,Long N J,Gee A D,et al.Angew Chem Int Ed,2008,47(47):8998-9033.
  • 4Okarvi S M.Eur J Nucl Med,2001,28(7):929-938.
  • 5Kolb H C,Finn M G,Sharpless K B.Angew Chem Int Ed,2001,40(11):2004-2021.
  • 6Kolb H C,Sharpless K B.Drug Discovery Today,2003,24(8):1128-1137.
  • 7Victoria D B,Hiemstra H,Maarseveen V J H.Eur J Org Chem,2006(1):51-68.
  • 8Shen J,Woodward R,Kedenburg J P,et al.J Med Chem,2008,51(23):7417-7427.
  • 9Binder W H,Sachsenhofer R.Macromol Rapid Commun,2007,28(1):15-54.
  • 10Zhang Q,Ning Z J,Yah Y L,et al.Macromol Rapid Commun,2008,29(3):193-201.

二级参考文献19

  • 1Ruoslahti E. The RGD story: a personal account. Matrix Biol [J]. 2003, 22(6): 459-465.
  • 2Wickham, TJ, Mathias P, Cheresh DA, et al. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachement [ J ]. Cell, 1993, 73(2): 309-319.
  • 3Marcinkiewicz C. Functional characteristic of snake venom disintegrins: potential therapeutic implication [J]. Curr Pharm Des, 2005, 11(7): 815-827.
  • 4Ahmed N, Riley C, Rice G, et al. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment[ J]. Clin Exp Metastasis, 2005, 22(5): 391--402.
  • 5Janssen ML, Oyen WJ, Dijkgraaf I, et al. Tumor targeting with radiolabeled alpha (v)beta(3) integrin binding peptides in a nude mouse model[ J ]. Cancer Res, 2002, 62(21 ): 6146-6151.
  • 6Zheng DQ, Woodard AS, Fornaro M, et al. Prostatic carcinoma cell migration via alpha (v) beta (3) integrin is modulated by focal adhesion kinase pathway [ J ]. Cancer Res, 1999, 59(2): 1655 - 1664.
  • 7Vonlaufen A, Wiedle G, Borisch B, et al. Integrin αvβ3 expression in colon carcinoma correlates with survival [J ]. Mod Pathol, 2001, 14(11): 1126-1131.
  • 8Kanamori M, Kawaguchi T, Berger MS, et al. Intracranial microenvironment reveals independent opposing functions of host alphaV beta3 expression on glioma growth and angiogenesis [ J ]. J Biol Chem, 2006, 281(48): 37256-37264.
  • 9Zhao M, Wang C, Jiang X, et al. Synthesis of RGD containing peptides and their bioactivities [J]. Prep Biochem Biotechnol, 2002, 32(4): 363-380.
  • 10Bogdanowich-Knipp SJ, Chakrabarti S, Williams TD, et al. Solution stability of linear vs. cyclic RGD peptides[J]. J Pept Res, 1999, 53(5): 530-541.

同被引文献29

  • 1武凤玉,左书耀.放射性核素标记奥曲肽肿瘤受体显像研究进展[J].国外医学(肿瘤学分册),2005,32(10):760-763. 被引量:6
  • 2张锦明,田嘉禾.国内正电子放射性药物发展现状简介[J].同位素,2006,19(4):240-245. 被引量:23
  • 3Guhlke S, Wester HJ, Bruns C, et al. (2-[lSF] fluoropropionyl-(d) phel)- octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: Synthesis, radiolabel ing, in vitro validation and biodistribution in mice [J]. Nuclear Medicine and Biology, 1994, 21: 819-825.
  • 4Wester HJ, Brockmann J, Rosch F, et al. PET- Pharmacokinetics of 18 F-Octreotide : A Comparison with 67Ga_DFO_ and 86 Y-DTPA-Octreotide [J]. Nuclear Medicine & Biology, 1997, 24: 275-286.
  • 5Wester H J, Sehottelius M, Scheidhauer K, et al. PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F" labelled, carbohydrated analogue of octreotide[J]. European Journal of Nuclear Medicine and Molecu lar Imaging, 2003, 30: 117-122.
  • 6Meisetsehliger G, Poethko T, Stahl A, et al. Gluc-Lys(Es FFP)-TOCA PET in Patients with SSTR- Positive Tumors: Biodistribution and Diagnostic Evaluation Compared with [-H InDTPA- Octreotide[J]. The Journal of Nuclear Medcine, 2006, 47, 4:566 573.
  • 7Schirrmacher E, Wingler B, Cypryk M, et al. Synthesis of p (Di tert-butyl ETM F fluorosilyl) benzaldehyde (EJs FJSiFA-A) with High Specific Activity by Isotopic Exchange: A Convenient La- beling Synthon for the sF_Labeling of N amino- oxy Derivatized Peptides[J]. Bioconjugate Chem, 2007, 18:2 085-2 089.
  • 8Hohne A, Mu L, Honer M, et al. Synthesis, 18F- Labeling, and in Vitro and in Vivo Studies of Bombesin Peptides Modified with Silicon-Based Building Blocks [J]. Bioconjugate Chem, 2008, 19:1 871-1 879.
  • 9W/ingler C, Waser B, Alke A, et al. One-Step 18F-Labeling of Carbohydrate-Conjugated Octr- eotate-Derivatives Containing a Silicon-Fluoride Acceptor (SiFA) : In Vitro and in Vivo Evaluation as Tumor Imaging Agents for Positron Emission Tomography (PET) [J]. Bioconjugate Chem, 2010, 21 (12): 2 289-2 296.
  • 10McBride WJ, Sharkey RM, Karacay H. A Novel Method of 18F Radiolabeling for PET[J]. Nucl Med, 2009, 50: 991-998.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部